(1)
Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients. jrenhep 2020, 4 (1), 22-30. https://doi.org/10.15586/jrenhep.2020.61.